Loading stock data…
$5.95-0.03 (-0.50%)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally.
LifeVantage Corporation in the Consumer Defensive sector is trading at $5.95 with a market capitalization of $80M. Wall Street consensus targets $7.50 (2 analysts), implying a +26.1% move over the next 12 months. The stock is currently 49% below its 52-week high of $11.71, remaining 1.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $42.38M↓ | $43.72M↓ | $48.93M↑ | $47.56M↓ | $55.11M |
| Gross Profit | $33.04M↓ | $34.54M↓ | $36.21M↓ | $37.82M↓ | $44.05M |
| Operating Income | $1.67M↓ | $1.68M↑ | $487,000↓ | $2.27M↑ | $2.15M |
| Net Income | $1.28M↓ | $1.36M↑ | $276,000↓ | $2.15M↑ | $1.96M |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United Sta...